Business Context and Reporting Period
This Form 8-K was filed by Target Corporation on December 16, 2015. The report details the entry into a Material Definitive Agreement on the same date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate transaction rather than periodic financial performance.
Material Changes
On December 16, 2015, Target Corporation entered into a Pharmacy Operating Agreement ("POC") with CVS Pharmacy, Inc. This agreement was executed in connection with the closing of transactions under an Asset Purchase Agreement ("APA") dated June 12, 2015, pursuant to which Target sold its pharmacy and clinic businesses to CVS.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future outlook, or specific risk factors beyond the transaction details. The material terms of the APA and POC were previously described in Target's Form 8-K filed on June 15, 2015.
Investor Verification Checklist
- Verify the closing status of the pharmacy and clinic business sale to CVS Pharmacy, Inc.
- Review the June 15, 2015 Form 8-K for the detailed material terms of the Asset Purchase Agreement and Pharmacy Operating Agreement.
- Confirm the impact of the divestiture on Target's future operational structure and revenue streams.